Filing Flows › Comparisons › GIPL vs GUTS
Global Innovative Platforms vs Fractyl Health: GIPL and GUTS compared
Global Innovative Platforms is the larger company: $51K of revenue in its latest quarter (Q3 FY26) against $3K for Fractyl Health (Q4 2024).
Where the money goes: GIPL and GUTS
Global Innovative Platforms (GIPL) · Q3 FY26
Global Innovative Platforms, Q3 FY26: revenue $51K, operating margin -476.6%, net loss $242K, operating cash flow −$134K. The chart follows the revenue to costs, profit and cash.
Fractyl Health (GUTS) · Q4 2024
Fractyl Health, Q4 2024: revenue $3K (-57% year over year), net loss $25.0M, operating cash flow −$17.0M. The chart follows the revenue to costs, profit and cash.
| Global Innovative Platforms (GIPL) | Fractyl Health (GUTS) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q4 2024 |
| Revenue | $51K | $3K |
| Revenue growth, Y/Y | — | -57% |
| Operating margin | -476.6% | n/m |
| Net earnings | −$242K | −$25.0M |
| Net margin | -476.5% | — |
| Operating cash flow | −$134K | −$17.0M |
Questions
Which is bigger, Global Innovative Platforms or Fractyl Health?
Global Innovative Platforms is the larger company: $51K of revenue in its latest quarter (Q3 FY26) against $3K for Fractyl Health (Q4 2024).
More: Global Innovative Platforms earnings · how Global Innovative Platforms makes money · Fractyl Health earnings · how Fractyl Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-K filed Mar 3, 2025). Fiscal quarters can end on different dates. Not investment advice.